Able To Commercialise Molecule By Q3 & Q4
12-Jun-2026 19:06:11NDTVGeneral newsAnlon Health , MD Says Expect To Achieve EBITDA Margin Of 25% In H1 - NDTV PROFITAble To Commercialise Molecule By Q3 & Q4NDTV LTD← Back to feed